ATRC Atricure, Inc.

$28.84 +6.34%

Healthcare · Surgical & Medical Instruments & Apparatus

Atricure, Inc. (ATRC) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.5 billion. Shares last traded at $28.84, 33.9% below their 52-week high. Over the past year the stock is down 11.6%. Net profit margin is -2.1%, above the peer median of -7.6%. Revenue grew 14.9% year over year.

Market Cap

$1.5B

Shares Out

50.6M

EPS (TTM)

$-0.69

P/E Ratio

—

P/S Ratio

2.73

P/B Ratio

2.97

Dividend / Share

—

Dividend Yield

—

52-Week High

$43.60

52-Week Low

$25.39

Volume

93,664

Avg Vol (3m)

49,342.127

Performance

+1.51%

+0.14%

-0.62%

-29.78%

YTD

-26.54%

-11.56%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

55.46

SMA (50)

$28.09

SMA (200)

$33.46

Price vs SMA50

+2.69%

Price vs SMA200

-13.80%

ATR (14)

$1.42

Financials

Revenue

$535M

Net Income

$-11M

Gross Margin

75.0%

Operating Margin

-1.8%

Net Margin

-2.1%

Return on Equity

-2.3%

Return on Assets

-1.8%

Current Ratio

4.29

Debt / Equity

0.12

Revenue Growth (YoY)

+14.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.00	2026-05-06
FY 2025	$-0.24	2026-02-19
Q3 2025	$-0.28	2025-10-30
Q2 2025	$-0.27	2025-07-30
Q1 2026	$-0.14	2026-05-06
FY 2025	$-0.95	2026-02-19

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

ATRC vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.73 / 2.52 med

+8% premium

Net margin vs peers

-2.1% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.